IRCT20190122042450N5招募中2 期
A Comparison between the Effect of Empagliflozin and Pioglitazon on Echocardiographic Indices in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 no limit（—）
- 性别
- All
入选标准
- •Type 2 diabetes mellitus (T2DM)
- •HbA1C between 7-10.5%
- •Non-alcoholic fatty liver disease (NAFLD) with cap score >302 dB/m
- •Normal Ejection Fraction (EF=50%)
排除标准
- •??Arrhythmia
- •Ischemic or non Ischemic heart disease
- •Peripheral artery disease
- •Current use of SGLT2 inhibitors
- •Current use of Glucagone like peptide 1 receptor agonist
- •Current use of Thiazolidendions
- •Current use of Tamoxifen
- •Current use of Amiodarone
- •Current use of Nonsteroid anti inflammatory agents
- •Current use of Vitamin C
- •Current use of Vitamin E
- •Current use of Selenium
- •Current use of other antioxidants
- •Breast feeding
- •Hypothyroidism
- •Hyperthyroidism
- •Hepatitis B
- •Hepatitis C
- •Autoimmune Hepatitis
- •Any form of chronic liver disease except fatty liver disease
- •Alcohol consumption more than 30 gr/day in men
- •Alcohol consumption more than 20 gr/day in women
- •eGFR<45 cc/min/1.73 m2
- •Corticosteroid use at least 14 days in the past month
- •Active cancer
- •History of the treated cancer in the past 2 years.
- •Current use of fibrates
研究者
相似试验
招募中
3 期
Effect of Empagliflozin in PrediabetesCondition 1: Impaired fasting glucose. Condition 2: Impaired glucose tolerance.Impaired fasting glucoseImpaired glucose tolerance (oral)R73.01R73.02IRCT20220902055858N1Shahre-kord University of Medical Sciences90
已完成
2 期
Investigating the Empagliflozin effect on nonalcoholic fatty liver in patients with diabetic type 2 with metformin-containing regimensType 2 diabetic patients with nonalcoholic fatty liver disease.type 2 diabetes mellitus, nonalcoholic fatty liver disease5A11, DB92IRCT20220115053717N1Oroumia University of Medical Sciences60
已完成
2 期
The effect of empagliflozin on nonalcoholic fatty liver disease in diabetic patientsIRCT20190122042450N3Iran University of Medical Sciences105
尚未招募
3 期
Evaluation of the effect of Empagliflozin on the severity of heart failure symptoms and echocardiography parameters in patients with congenital heart diseases with left-to-right shuntIRCT20120520009801N11Mashhad University of Medical Sciences44
招募中
3 期
Empagliflozin in heart failure without diabetesHeart failureHeart Failure.IRCT20210828052313N1Shiraz University of Medical Sciences300